Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity

Tetsuji Shinohara, Daehyeok Kim, Boyoung Joung, Mitsunori Maruyama, Kannan Vembaiyan, Thomas G. Back, S. R. Wayne Chen, Peng Sheng Chen, Shien Fong Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The membrane voltage clock and calcium (Ca2+) clock jointly regulate sinoatrial node (SAN) automaticity. VK-II-36 is a novel carvedilol analog that suppresses sarcoplasmic reticulum (SR) Ca2+ release but does not block the b-receptor. The effect of VK-II-36 on SAN function remains unclear. The purpose of this study was to evaluate whether VK-II-36 can influence SAN automaticity by inhibiting the Ca2+ clock. We simultaneously mapped intracellular Ca2+ and membrane potential in 24 isolated canine right atriums using previously described criteria of the timing of late diastolic intracellular Ca elevation (LDCAE) relative to the action potential upstroke to detect the Ca2+ clock. Pharmacological interventions with isoproterenol (ISO), ryanodine, caffeine, and VK-II-36 were performed after baseline recordings. VK-II-36 caused sinus rate downregulation and reduced LDCAE in the pacemaking site under basal conditions (P < 0.01). ISO induced an upward shift of the pacemaking site in SAN and augmented LDCAE in the pacemaking site. ISO also significantly and dose-dependently increased the sinus rate. The treatment of VK-II-36 (30 μmol/l) abolished both the ISO-induced shift of the pacemaking site and augmentation of LDCAE ( P < 0.01), and it suppressed the ISO-induced increase in sinus rate (P = 0.02). Our results suggest that the sinus rate may be partly controlled by the Ca 2+ clock via SR Ca2+ release during β-adrenergic stimulation.

Original languageEnglish
Pages (from-to)396-403
Number of pages8
JournalHeart and Vessels
Volume29
Issue number3
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Sinoatrial Node
Isoproterenol
Sarcoplasmic Reticulum
Ryanodine
Intracellular Membranes
Caffeine
Heart Atria
Adrenergic Agents
Membrane Potentials
Action Potentials
Canidae
Down-Regulation
carvedilol
Pharmacology
Calcium
Membranes

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Shinohara, T., Kim, D., Joung, B., Maruyama, M., Vembaiyan, K., Back, T. G., ... Lin, S. F. (2014). Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity. Heart and Vessels, 29(3), 396-403. https://doi.org/10.1007/s00380-013-0378-2
Shinohara, Tetsuji ; Kim, Daehyeok ; Joung, Boyoung ; Maruyama, Mitsunori ; Vembaiyan, Kannan ; Back, Thomas G. ; Wayne Chen, S. R. ; Chen, Peng Sheng ; Lin, Shien Fong. / Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity. In: Heart and Vessels. 2014 ; Vol. 29, No. 3. pp. 396-403.
@article{b13c5908cb6d4756bd872e9512df960e,
title = "Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity",
abstract = "The membrane voltage clock and calcium (Ca2+) clock jointly regulate sinoatrial node (SAN) automaticity. VK-II-36 is a novel carvedilol analog that suppresses sarcoplasmic reticulum (SR) Ca2+ release but does not block the b-receptor. The effect of VK-II-36 on SAN function remains unclear. The purpose of this study was to evaluate whether VK-II-36 can influence SAN automaticity by inhibiting the Ca2+ clock. We simultaneously mapped intracellular Ca2+ and membrane potential in 24 isolated canine right atriums using previously described criteria of the timing of late diastolic intracellular Ca elevation (LDCAE) relative to the action potential upstroke to detect the Ca2+ clock. Pharmacological interventions with isoproterenol (ISO), ryanodine, caffeine, and VK-II-36 were performed after baseline recordings. VK-II-36 caused sinus rate downregulation and reduced LDCAE in the pacemaking site under basal conditions (P < 0.01). ISO induced an upward shift of the pacemaking site in SAN and augmented LDCAE in the pacemaking site. ISO also significantly and dose-dependently increased the sinus rate. The treatment of VK-II-36 (30 μmol/l) abolished both the ISO-induced shift of the pacemaking site and augmentation of LDCAE ( P < 0.01), and it suppressed the ISO-induced increase in sinus rate (P = 0.02). Our results suggest that the sinus rate may be partly controlled by the Ca 2+ clock via SR Ca2+ release during β-adrenergic stimulation.",
author = "Tetsuji Shinohara and Daehyeok Kim and Boyoung Joung and Mitsunori Maruyama and Kannan Vembaiyan and Back, {Thomas G.} and {Wayne Chen}, {S. R.} and Chen, {Peng Sheng} and Lin, {Shien Fong}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00380-013-0378-2",
language = "English",
volume = "29",
pages = "396--403",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "3",

}

Shinohara, T, Kim, D, Joung, B, Maruyama, M, Vembaiyan, K, Back, TG, Wayne Chen, SR, Chen, PS & Lin, SF 2014, 'Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity', Heart and Vessels, vol. 29, no. 3, pp. 396-403. https://doi.org/10.1007/s00380-013-0378-2

Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity. / Shinohara, Tetsuji; Kim, Daehyeok; Joung, Boyoung; Maruyama, Mitsunori; Vembaiyan, Kannan; Back, Thomas G.; Wayne Chen, S. R.; Chen, Peng Sheng; Lin, Shien Fong.

In: Heart and Vessels, Vol. 29, No. 3, 01.01.2014, p. 396-403.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Carvedilol analog modulates both basal and stimulated sinoatrial node automaticity

AU - Shinohara, Tetsuji

AU - Kim, Daehyeok

AU - Joung, Boyoung

AU - Maruyama, Mitsunori

AU - Vembaiyan, Kannan

AU - Back, Thomas G.

AU - Wayne Chen, S. R.

AU - Chen, Peng Sheng

AU - Lin, Shien Fong

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The membrane voltage clock and calcium (Ca2+) clock jointly regulate sinoatrial node (SAN) automaticity. VK-II-36 is a novel carvedilol analog that suppresses sarcoplasmic reticulum (SR) Ca2+ release but does not block the b-receptor. The effect of VK-II-36 on SAN function remains unclear. The purpose of this study was to evaluate whether VK-II-36 can influence SAN automaticity by inhibiting the Ca2+ clock. We simultaneously mapped intracellular Ca2+ and membrane potential in 24 isolated canine right atriums using previously described criteria of the timing of late diastolic intracellular Ca elevation (LDCAE) relative to the action potential upstroke to detect the Ca2+ clock. Pharmacological interventions with isoproterenol (ISO), ryanodine, caffeine, and VK-II-36 were performed after baseline recordings. VK-II-36 caused sinus rate downregulation and reduced LDCAE in the pacemaking site under basal conditions (P < 0.01). ISO induced an upward shift of the pacemaking site in SAN and augmented LDCAE in the pacemaking site. ISO also significantly and dose-dependently increased the sinus rate. The treatment of VK-II-36 (30 μmol/l) abolished both the ISO-induced shift of the pacemaking site and augmentation of LDCAE ( P < 0.01), and it suppressed the ISO-induced increase in sinus rate (P = 0.02). Our results suggest that the sinus rate may be partly controlled by the Ca 2+ clock via SR Ca2+ release during β-adrenergic stimulation.

AB - The membrane voltage clock and calcium (Ca2+) clock jointly regulate sinoatrial node (SAN) automaticity. VK-II-36 is a novel carvedilol analog that suppresses sarcoplasmic reticulum (SR) Ca2+ release but does not block the b-receptor. The effect of VK-II-36 on SAN function remains unclear. The purpose of this study was to evaluate whether VK-II-36 can influence SAN automaticity by inhibiting the Ca2+ clock. We simultaneously mapped intracellular Ca2+ and membrane potential in 24 isolated canine right atriums using previously described criteria of the timing of late diastolic intracellular Ca elevation (LDCAE) relative to the action potential upstroke to detect the Ca2+ clock. Pharmacological interventions with isoproterenol (ISO), ryanodine, caffeine, and VK-II-36 were performed after baseline recordings. VK-II-36 caused sinus rate downregulation and reduced LDCAE in the pacemaking site under basal conditions (P < 0.01). ISO induced an upward shift of the pacemaking site in SAN and augmented LDCAE in the pacemaking site. ISO also significantly and dose-dependently increased the sinus rate. The treatment of VK-II-36 (30 μmol/l) abolished both the ISO-induced shift of the pacemaking site and augmentation of LDCAE ( P < 0.01), and it suppressed the ISO-induced increase in sinus rate (P = 0.02). Our results suggest that the sinus rate may be partly controlled by the Ca 2+ clock via SR Ca2+ release during β-adrenergic stimulation.

UR - http://www.scopus.com/inward/record.url?scp=84905187153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905187153&partnerID=8YFLogxK

U2 - 10.1007/s00380-013-0378-2

DO - 10.1007/s00380-013-0378-2

M3 - Article

C2 - 23836067

AN - SCOPUS:84905187153

VL - 29

SP - 396

EP - 403

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 3

ER -